Business Context and Reporting Period
Company: Exponent, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: April 2, 2004
Business Overview: Exponent is an engineering and scientific consulting firm providing solutions to complex problems through multidisciplinary teams. The company operates two primary segments: "Other Scientific and Engineering" (litigation support, technology development) and "Environmental and Health" (environmental hazards, epidemiology).
Key Financial Metrics
| Metric (in thousands) | Q1 2004 | Q1 2003 |
|---|---|---|
| Total Revenues | $38,766 | $34,815 |
| Operating Income | $5,807 | $4,155 |
| Net Income | $3,521 | $2,469 |
| Diluted EPS | $0.43 | $0.32 |
| Operating Margin | 15.0% | 12.0% |
| Net Margin | 9.1% | 7.1% |
| Cash & Equivalents | $6,416 | $21,404 (End of Q1 2003) |
| Short-Term Investments | $32,240 | $22,268 (Jan 2, 2004) |
| Total Debt (Long-term) | $154 | $169 |
Liquidity: Total cash, cash equivalents, and short-term investments stood at $38.7 million as of April 2, 2004. The company maintains a revolving mortgage note with $22.9 million available and $0 outstanding.
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased 11.3% year-over-year, driven by a 16.2% increase in the "Other Scientific and Engineering" segment. This growth was attributed to a 7.8% increase in total billable hours and higher billing rates.
- Profitability: Operating income rose 40% and net income increased 43% compared to the prior year quarter, reflecting effective cost management and revenue leverage.
- Segment Performance: While the "Other Scientific and Engineering" segment grew, the "Environmental and Health" segment saw a 1.3% revenue decline due to an 8% drop in billable hours and lower utilization rates (62% vs. 67%).
- Cash Flow: Net cash used in operating activities increased significantly to $3.7 million (from $0.6 million used in 2003), primarily due to a $5.9 million increase in accounts receivable. Days sales outstanding rose to 95 days from 81 days.
- Investing Activities: Net cash used in investing activities was $10.2 million, largely due to $10.5 million in purchases of short-term investments.
Guidance, Outlook, and Risks
Management Commentary: Management anticipates an increase in compensation expenses due to a 5% annual salary increase effective April 2004. The company expects to continue investing in short-term investments and capital expenditures. Cash reserves may be utilized for stock repurchases, strategic acquisitions, or dividends.
Stock Repurchase Program: As of April 2, 2004, the company had $4.711 million remaining authorization under its stock repurchase plans ($1.711 million from Feb 2003 approval and $3.0 million from Aug 2003 approval).
Risks and Contingencies:
- Backlog: The company operates with minimal backlog, making future revenue difficult to predict based on current order books.
- Customer Concentration: Significant revenue is derived from the transportation industry and government sector; loss of a major client could materially impact results.
- Key Personnel: Success depends on attracting and retaining highly qualified technical staff in a competitive market.
- Regulatory/Tort Reform: Changes in environmental laws or tort reform reducing liability exposure could decrease demand for litigation support services.
- Unusual Items: Other operating expenses included a $230,000 write-off of a foreign real estate investment. General and administrative expenses included a $200,000 increase in bad debt expense.
Investor Verification Checklist
- Accounts Receivable Aging: Verify the collectibility of the $41.2 million receivable balance, noting the increase in days sales outstanding to 95 days.
- Utilization Rates: Monitor the trend in the "Environmental and Health" segment, where utilization dropped to 62%.
- Compensation Costs: Assess the impact of the 5% salary increase and bonus accruals on future margins.
- Investment Portfolio: Review the composition and unrealized gains/losses of the $32.2 million short-term investment portfolio.
- Stock-Based Compensation: Note the pro-forma impact of fair value accounting on net income (adjusted diluted EPS would be $0.38 vs. reported $0.43).